Health Condition 1: O- Medical and Surgical Health Condition 2: H110- Pterygium of eye
Conditions
Interventions
Intervention1: Amniotic Membrane Graft,
0.025% Mitomycin C with Conjunctival Autograft: Amniotic Membrane Graft: This involves using amniotic membrane to repair the pterygium on the eyes surface.
0.0
Sponsors
Veer Chandra Singh Garhwali Government Institute of Medical Science and Research
Eligibility
Inclusion criteria
Inclusion criteria: a. Patients diagnosed with primary pterygium. b. Adults (18 years and older)
Exclusion criteria
Exclusion criteria: a. Patients with recurrent pterygium, severe ocular conditions, such as advanced glaucoma, corneal dystrophy, or significant ocular surface disease. b. Combined surgical procedures at the time of surgery like trabeculectomy, cataract surgery. c. Macular degeneration or any other retinal pathology were excluded. d. With systemic connective tissue disorders. e. Inability to give informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graftTimepoint: Comparison of the effectiveness will be notice at 1 week and 1 month | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graftTimepoint: Effectiveness of recurrence after 2 months | — |
Countries
India
Contacts
Public ContactNikita Bilania
Veer Chandra Singh Garhwali Government Institute of Medical Science and Research
Outcome results
None listed